Sign In
Buy XOMA
$41.70
+0.0100 (+0.0240%)
At Close: Jun 03, 2026
Strength Seen in Xoma (XOMA): Can Its 11.2% Jump Turn into More Strength?
04:53am, Friday, 08'th Oct 2021
Xoma (XOMA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
XOMA to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference
07:30am, Wednesday, 22'nd Sep 2021
EMERYVILLE, Calif., Sept. 22, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA)'s Chief Executive Officer, Jim Neal, will present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Confere
XOMA Declares Quarterly Preferred Stock Dividends
07:30am, Monday, 20'th Sep 2021
EMERYVILLE, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash divide
XOMA to Present at H.C. Wainwright 23rd Annual Global Investment Conference
07:30am, Monday, 13'th Sep 2021
EMERYVILLE, Calif., Sept. 13, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today its Chief Executive Officer, Jim Neal, will present at the H.C. Wainwright 23rd Annual Global Inv
I Put Half Of My Retirement Savings Into These Investments
08:35am, Thursday, 02'nd Sep 2021
Half of my retirement savings is invested in two sectors.
XOMA Announces Heather L. Franklin Joins its Board of Directors
04:35pm, Tuesday, 10'th Aug 2021
EMERYVILLE, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today Heather L. Franklin, President and Chief Executive Officer of Blaze Bioscience, Inc., has joined t
XOMA Reports Second Quarter 2021 Financial Results and Highlights Recent Operational Events
07:30am, Thursday, 05'th Aug 2021
Added six assets to its portfolio of potential milestone and royalty assets in 2021
Ad hoc announcement pursuant to Article 53 of the SIX listing rules Ad hoc announcement pursuant to Article 53 of the SIX listing rules
XOMA Acquires Royalty and Milestone Interest in Checkmate's Vidutolimod (CMP-001) from Kuros Biosciences
04:00am, Thursday, 15'th Jul 2021
EMERYVILLE, Calif., July 15, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), announced today it has acquired the royalty interest position Kuros Biosciences holds in Checkmate Pharmaceutical
Stem, Tesla, Textron, Two Harbors and More Tuesday Afternoon Analyst Calls
01:16pm, Tuesday, 29'th Jun 2021
Stocks were mostly higher in midday Tuesday trading, after both the S&P 500 and the Nasdaq closed at record highs on Monday.
XOMA Declares Quarterly Preferred Stock Dividends
07:30am, Monday, 21'st Jun 2021
EMERYVILLE, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividen
XOMA Licensees to Present Significant Clinical Data at 2021 ASCO Annual Meeting
08:00am, Friday, 21'st May 2021
EMERYVILLE, Calif., May 21, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) recently learned its licensees are presenting at the upcoming 2021 American Society of Clinical Oncology (ASCO) An
XOMA Earns Milestone for First Patient Dosed in Phase 3 Development Program
07:30am, Monday, 03'rd May 2021
EMERYVILLE, Calif., May 03, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced it has earned a $0.5 million milestone from Janssen Biotech, Inc.
New Preferred Stock IPOs, April 2021
01:27pm, Tuesday, 27'th Apr 2021
New Preferred Stock IPOs, April 2021
XOMA's Royalty Portfolio Grows with Addition of Three Royalty Assets
09:05am, Thursday, 15'th Apr 2021
EMERYVILLE, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) today announced its portfolio of potential future milestone and royalty assets has increased with the addition of
